Skip to content

CRISPR

CRISPR-Cas is a gene-editing technology that uses programmable enzymes to cut and modify DNA, widely used in research, medicine, and biotechnology.

Known aliases

  • CRISPR-Cas
  • CRISPR gene editing
  • CRISPR screens

Current stories

science1 publisherOne report

Researcher who shared drafts with Claude questions Anthropic's enzyme-discovery claim

Copenhagen PhD candidate Mario Rodríguez Mestre questions whether Anthropic's Claude independently found an enzyme family his team has studied since 2022. Credit for the find is unsettled, and the case shows how little a scientist can check once unpublished work has gone into a commercial chatbot.

Publishers:phys.org

Reality

Evidence38
Adoption
Insufficient
Hype gap+45
Incentives60
Confidence40
product1 publisherOne report

Anthropic's Crispr-like find from 950 Claude agents still waits on the wet lab

Anthropic says about 950 Claude agents found an enzyme system reminiscent of Crispr in 21.5 hours, backed so far by one unreviewed lab experiment. Scientists credit the speed of the search, so a lab can budget for faster triage today while the bench works out what the enzyme does.

Publishers:wired.com

Reality

Evidence35
Adoption
Insufficient
Hype gap+45
Incentives70
Confidence50
build5 publishersConfirmed

Anthropic's 950 Claude agents spent 210 million tokens to hand biologists 20 enzyme leads

Anthropic ran about 950 Claude agents for 21 hours on 210 million tokens to cut over 200,000 reverse transcriptases to 20 lab candidates. Human scientists kept the bench work, so lab capacity sets how fast those leads get tested.

Perspective Coverage

5 publishers
Builder
Builder 45%
Operator
Operator 36%
Investor
Investor 19%

Reality

Evidence46
Adoption
Insufficient
Hype gap+48
Incentives80
Confidence64
product1 publisherOne report

United Therapeutics launches world's first pig-kidney clinical trial

United Therapeutics is sponsoring the first xenotransplant clinical trial. Its first patient got a 10-edit pig kidney at NYU Langone in November. The longest a gene-edited pig kidney has worked in a person is 271 days, against years or decades for a human donor organ.

Publishers:gizmodo.com

Reality

Evidence52
Adoption31
Hype gap+22
Incentives72
Confidence44
science3 publishersConfirmed

Six mice per arm put the disputed PTBP1 conversion route back in the argument

Peisheng Xu's group degraded the PTBP1 protein with antibodies ferried past the blood-brain barrier, and human astrocytes in a dish turned into firing neurons. In living mice, the lineage question is still open.

Perspective Coverage

3 publishers
Builder
Builder 45%
Operator
Operator 32%
Investor
Investor 23%

Reality

Evidence44
Adoption6
Hype gap+34
Incentives63
Confidence61